This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Embera NeuroTherapeutics, Inc.
Drug Names(s): EMB001, OX/MET
Description: EMB-001 is the combination use of benzodiazepine oxazepam and the cortisol synthesis inhibitor metyrapone. The compounds uniquely modulate stress-related pathways like the corticotropin-releasing factor (CRF) and the gamma-aminobutyric acid (GABA) system.
Additional information available to subscribers only: